Home Healthcare Biotechnology Neoantigen Cancer Vaccine Market

Neoantigen Cancer Vaccine Market Size, Share & Trends Analysis Report By Product (Personalised Neoantigen Vaccine, Off-the-Shelf Neoantigen Vaccine), By Neoantigen Type (Synthetic Long Peptide, Nucleic Acid, Dendritic Cell, Tumour Cell), By Route of Administration (Intravenous, Intramuscular, Transdermal, Others), By Cell (Autologous, Allogenic), By Technology (RNA Sequencing, Whole Genome Sequencing, HLA Typing), By Delivery Mechanism (Liposomes, Virosomes, Gene Gun, Electroporation, Others), By Application (Lung, Melanoma, Gastrointestinal, Others), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
  7. North America Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  8. Europe Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    11. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    12. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    13. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    14. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    15. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    16. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    17. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  9. APAC Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    11. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    12. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    13. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    14. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    15. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    16. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  10. Middle East and Africa Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    11. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    12. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    13. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    14. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    15. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  11. LATAM Neoantigen Cancer Vaccine Market Size Analysis
    1. Introduction
    2. Neoantigen Cancer Vaccine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Personalised neo-antigen vaccine
      2. Off-the-shelf neoantigen vaccine
    3. Neoantigen Cancer Vaccine Market Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
      1. Synthetic Long Peptide
      2. Nucleic acid
      3. Dendritic cell
      4. Tumour cell
    4. Neoantigen Cancer Vaccine Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Intramuscular
      3. Transdermal
      4. Others
    5. Neoantigen Cancer Vaccine Market Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
      1. Autologous
      2. Allogenic
    6. Neoantigen Cancer Vaccine Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Sequencing
      2. Whole Genome Sequencing
      3. HLA Typing
    7. Neoantigen Cancer Vaccine Market Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
      1. Liposomes
      2. Virosomes
      3. Gene gun
      4. Electroporation
      5. Others
    8. Neoantigen Cancer Vaccine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Lung
      2. Melanoma
      3. Gastrointestinal
      4. Brain cancer
      5. Others
    9. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    10. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    11. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    12. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    13. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
    14. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      3. Market Size & Forecast By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      5. Market Size & Forecast By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      6. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      7. Market Size & Forecast By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      8. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
  12. Competitive Landscape
    1. Neoantigen Cancer Vaccine Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. OSE Immunotherapeutics SA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Gritstone bio Inc.
    3. BioNTech SE
    4. Hoffmann-La Roche Ltd.
    5. Pfizer Inc.
    6. Merck & Co. Inc.
    7. Moderna Inc.
    8. Avidea Technologies Inc.
    9. Eli Lilly and Company
    10. Vaccibody AS
    11. Agenus Inc.
    12. Novogene Co. Ltd.
    13. ZIOPHARM Oncology Inc.
    14. ISA Pharmaceuticals B.V.
    15. BrightPath Biotherapeutics Co. Ltd.
    16. Vaximm AG
    17. Medigene AG
    18. Genocea Biosciences Inc.
    19. Advaxis Inc.
    20. Nouscom AG
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.